{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:07:45Z","timestamp":1780621665279,"version":"3.54.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371857"],"award-info":[{"award-number":["81371857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The Mycobacterial heparin-binding hemagglutinin (HBHA) is an important latency-associated antigen that can be used to distinguish between latent tuberculosis infection (LTBI) and active tuberculosis (ATB). Although many studies were explored the efficiency of the HBHA-induced interferon-\u03b3 release assay (IGRA) in different populations, the clinical differential value of HBHA-IGRA is still controversial. Therefore, the aim of this study was to determine whether the HBHA-IGRA can be used as an efficient test for the discrimination of LTBI and ATB by a systematic review and meta-analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Relevant articles were retrieved from PubMed, Embase, Web of Science, and the Cochrane Library on Oct 18, 2020, with no start date limitation. The quality of each study was evaluated using Review Manager 5.4. The Stata MP v.14.0 software was used to combine sensitivity, specificity, likelihood ratio (LR), diagnostic odds ratio (DOR), summary receiver operating characteristic (SROC) curve, and area under SROC (AUC) to evaluate the diagnostic value of HBHA-IGRA for discrimination of LTBI and ATB. Meta-regression and subgroup analysis were performed for the sources of heterogeneity based on the selection criteria for active TB, the population, the TB burden, the type of antigen, the type of sample, and the time of antigen stimulation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 13 studies (14 results) were included in this meta-analysis, including 603 ATB patients and 514 LTBI individuals. The pooled sensitivity and specificity of the HBHA-IGRA for discrimination of the LTBI and ATB were 0.70 (95% CI, 0.57~0.80) and 0.78 (95% CI, 0.71~0.84), respectively. The pooled positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were 3.15 (95%CI, 2.43~4.09), 0.39 (95% CI, 0.27~0.56), and 8.11 (95% CI, 4.81~13.67), respectively. The AUC was 0.81 (95% CI, 0.77~0.84). The subgroup analysis showed that the main source of heterogeneity was due to the HIV-infected population incorporated, and the different selection criteria of active TB subjects would also lead to the variation of the pooled sensitivity and specificity. Different TB burdens, HBHA antigen types, sample types, antigen stimulation time and BCG vaccination did not affect the heterogeneity in this analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The HBHA-IGRA is a promising immunodiagnostic test for discrimination of latent and active TB, which can be added in commercial IGRAs to enhance the differential diagnostic performance.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0254571","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T17:40:10Z","timestamp":1626457210000},"page":"e0254571","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-\u03b3 release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5492-117X","authenticated-orcid":true,"given":"Jinhua","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"pone.0254571.ref001","unstructured":"World Health Organization. Global Tuberculosis Report 2020. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/data. Accessed February 25, 2021."},{"key":"pone.0254571.ref002","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. https:\/\/www.who.int\/tb\/publications\/latent-tuberculosis-infection\/en\/. Accessed February 25, 2021."},{"key":"pone.0254571.ref003","unstructured":"World Health Organization. Latent TB infection: updated and consolidated guidelines for programmatic management. https:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection\/en\/. Accessed February 25, 2021."},{"issue":"12","key":"pone.0254571.ref004","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1473-3099(20)30276-0","article-title":"Interferon-\u03b3 release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis","volume":"20","author":"G Zhou","year":"2020","journal-title":"Lancet Infect Dis."},{"issue":"3","key":"pone.0254571.ref005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00408-016-9872-5","article-title":"Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis: A Systematic Review and Meta-analysis","volume":"194","author":"P Lu","year":"2016","journal-title":"Lung"},{"issue":"1","key":"pone.0254571.ref006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"M Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"pone.0254571.ref007","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3389\/fmicb.2018.02258","article-title":"Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria","volume":"9","author":"D Raze","year":"2018","journal-title":"Front Microbiol"},{"issue":"3\u20134","key":"pone.0254571.ref008","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tube.2006.01.016","article-title":"Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis","volume":"86","author":"C Locht","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"pone.0254571.ref009","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3389\/fimmu.2018.02476","article-title":"A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis","volume":"9","author":"NR Meier","year":"2018","journal-title":"Front Immunol."},{"issue":"11","key":"pone.0254571.ref010","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2174\/0929867325666181029165805","article-title":"The Mycobacterial HBHA Protein: A Promising Biomarker for Tuberculosis","volume":"26","author":"F De Maio","year":"2019","journal-title":"Curr Med Chem"},{"issue":"12","key":"pone.0254571.ref011","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1586\/14760584.2015.1102638","article-title":"Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines","volume":"14","author":"F Mascart","year":"2015","journal-title":"Exp Rev Vacc"},{"issue":"7414","key":"pone.0254571.ref012","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"pone.0254571.ref013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/338833","article-title":"Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis","volume":"185","author":"C Masungi","year":"2002","journal-title":"J Infect Dis"},{"issue":"9","key":"pone.0254571.ref014","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nm1090","article-title":"Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin","volume":"10","author":"S Temmerman","year":"2004","journal-title":"Nat Med"},{"issue":"10","key":"pone.0254571.ref015","doi-asserted-by":"crossref","first-page":"e926","DOI":"10.1371\/journal.pone.0000926","article-title":"Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis","volume":"2","author":"JM Hougardy","year":"2007","journal-title":"PLoS One"},{"issue":"3","key":"pone.0254571.ref016","doi-asserted-by":"crossref","first-page":"e18315","DOI":"10.1371\/journal.pone.0018315","article-title":"Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders","volume":"6","author":"G Delogu","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"pone.0254571.ref017","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2011.08.010","article-title":"Tuberculosis patients are characterized by a low-IFN-\u03b3\/high-TNF-\u03b1 response to methylated HBHA produced in M. smegmatis","volume":"71","author":"P Molicotti","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"pone.0254571.ref018","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CVI.00651-13","article-title":"Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis","volume":"21","author":"C Wyndham-Thomas","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"pone.0254571.ref019","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/23744235.2015.1031173","article-title":"Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?","volume":"47","author":"P Molicotti","year":"2015","journal-title":"Infect Dis (Lond)."},{"issue":"8","key":"pone.0254571.ref020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10096-017-2948-1","article-title":"Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-\u03b3 release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations","volume":"36","author":"HL Wen","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"pone.0254571.ref021","doi-asserted-by":"crossref","first-page":"e0183846","DOI":"10.1371\/journal.pone.0183846","article-title":"Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection","volume":"12","author":"T Chiacchio","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"pone.0254571.ref022","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jinf.2018.09.011","article-title":"Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children","volume":"77","author":"M Sali","year":"2018","journal-title":"J Infect"},{"key":"pone.0254571.ref023","doi-asserted-by":"crossref","first-page":"101966","DOI":"10.1016\/j.tube.2020.101966","article-title":"QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-\u03b3 release assay improves the accuracy of identifying tuberculosis disease status","volume":"124","author":"J Tang","year":"2020","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"pone.0254571.ref024","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/QAI.0000000000000980","article-title":"Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda","volume":"72","author":"V Dirix","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"pone.0254571.ref025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/sji.12493","article-title":"Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection","volume":"84","author":"G Delogu","year":"2016","journal-title":"Scand J Immunol"},{"key":"pone.0254571.ref026","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"M Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"pone.0254571.ref027","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","article-title":"Tuberculosis: advances and challenges in development of new diagnostics and biomarkers","volume":"18","author":"G Walzl","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pone.0254571.ref028","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/resp.13272","article-title":"Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease","volume":"23","author":"D Goletti","year":"2018","journal-title":"Respirology"},{"key":"pone.0254571.ref029","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","article-title":"Diagnosis for Latent Tuberculosis Infection: New Alternatives","volume":"11","author":"C Carranza","year":"2020","journal-title":"Front Immunol"},{"key":"pone.0254571.ref030","first-page":"341","article-title":"Immunological Signatures Identifying Different Stages of Latent Mycobacterium tuberculosis Infection and Discriminating Latent from Active Tuberculosis in Humans","volume":"6","author":"K Smits","year":"2015","journal-title":"J Clin Cell Immunol"},{"issue":"7","key":"pone.0254571.ref031","doi-asserted-by":"crossref","first-page":"893","DOI":"10.17219\/acem\/121011","article-title":"Association between heparin-binding hemagglutinin and tuberculosis","volume":"29","author":"F Pu","year":"2020","journal-title":"Adv Clin Exp Med"},{"issue":"9","key":"pone.0254571.ref032","doi-asserted-by":"crossref","first-page":"e3272","DOI":"10.1371\/journal.pone.0003272","article-title":"Pilot study of diagnostic potential of the Mycobacterium tuberculosis recombinant HBHA protein in a vaccinated population in Finland","volume":"3","author":"L Savolainen","year":"2008","journal-title":"PLoS One"},{"key":"pone.0254571.ref033","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12879-015-0796-0","article-title":"Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube","volume":"15","author":"C Wyndham-Thomas","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pone.0254571.ref034","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/430930","article-title":"Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis","volume":"192","author":"ST Temmerman","year":"2005","journal-title":"J Infect Dis"},{"issue":"7","key":"pone.0254571.ref035","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.4049\/jimmunol.1901214","article-title":"Natural T Cell Epitope Containing Methyl Lysines on Mycobacterial Heparin-Binding Hemagglutinin","volume":"204","author":"V Corbi\u00e8re","year":"2020","journal-title":"J Immunol"},{"issue":"8","key":"pone.0254571.ref036","doi-asserted-by":"crossref","first-page":"e43285","DOI":"10.1371\/journal.pone.0043285","article-title":"Risk stratification of latent tuberculosis defined by combined interferon gamma release assays","volume":"7","author":"V Corbi\u00e8re","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"pone.0254571.ref037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2015.02.008","article-title":"Regulatory T-cell subsets in response to specific Mycobacterium tuberculosis antigens in vitro distinguish among individuals with different QTF and TST reactivity","volume":"157","author":"CJ Serrano","year":"2015","journal-title":"Clin Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T17:41:12Z","timestamp":1626457272000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254571"}},"subtitle":[],"editor":[{"given":"Olivier","family":"Neyrolles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0254571","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}